GENWORTH FINANCIAL INC
For the period ended Mar 31, 2025. Filed May 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 2, 2025
GNW$8.72+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Page | |||
|---|---|---|---|
| PART I—FINANCIAL INFORMATION | |||
| Item 1. · Financial Statements | |||
| Condensed Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 2024 | 3 | ||
| Condensed Consolidated Statements of Income for the three months ended March 31, 2025 and 2024 (Unaudited) | 4 | ||
| Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2025 and 2024 (Unaudited) | 5 | ||
| Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2025 and 2024 (Unaudited) | 6 | ||
| Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024 (Unaudited) | 7 | ||
| Notes to Condensed Consolidated Financial Statements (Unaudited) | 8 | ||
| Note 1 — Business and Basis of Presentation | 8 | ||
| Note 2 — Accounting Changes | 9 | ||
| Note 3 — Earnings (Loss) Per Share | 10 | ||
| Note 4 — Investments | 11 | ||
| Note 5 — Derivative Instruments | 25 | ||
| Note 6 — Fair Value of Financial Instruments | 30 | ||
| Note 7 — Deferred Acquisition Costs | 49 | ||
| Note 8 — Future Policy Benefits | 50 | ||
| Note 9 — Policyholder Account Balances | 55 | ||
| Note 10 — Additional Insurance Liabilities | 58 | ||
| Note 11 — Market Risk Benefits | 59 | ||
| Note 12 — Separate Accounts | 60 | ||
| Note 13 — Liability for Policy and Contract Claims | 61 | ||
| Note 14 — Income Taxes | 62 | ||
| Note 15 — Segment Information | 62 | ||
| Note 16 — Commitments and Contingencies | 65 | ||
| Note 17 — Changes in Accumulated Other Comprehensive Income (Loss) | 71 | ||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 73 | |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 110 | |
| Item 4. | Controls and Procedures | 110 | |
| PART II—OTHER INFORMATION | |||
| Item 1. | Legal Proceedings | 111 | |
| Item 1A. | Risk Factors | 111 | |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 111 | |
| Item 5. | Other Information | 111 | |
| Item 6. | Exhibits | 112 | |
| Signatures | 113 | ||
PART I—FINANCIAL INFORMATION
| Item 1. | Financial Statements |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.